Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Autoimmune Neurological Disorders and Treatments, and Functional Brain Connectivity Studies.
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia
Depressive Symptoms and Amyloid Pathology
Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer’s disease
The Clinical Trial Landscape in Autoimmune Encephalitis
The landscape of autosomal-dominant Alzheimer’s disease: global distribution and age of onset
An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration
Connectivity as a universal predictor of tau progression in atypical Alzheimer’s disease
The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease
Voiceprints of cognitive impairment: analyzing digital voice for early detection of Alzheimer’s and related dementias
Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis
PNMA2 forms immunogenic non-enveloped virus-like capsids associated with paraneoplastic neurological syndrome
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease
Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease
Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis
Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection‐related epilepsy syndrome) versus without prior fever: An interim analysis
Differences in baseline cognitive performance between participants with early‐onset and late‐onset Alzheimer's disease: Comparison of LEADS and ADNI
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer’s disease
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease
Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS)
Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)
The Sporadic Early‐onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) Cohort
Sex and <i>APOE ε4</i> carrier effects on atrophy, amyloid PET, and tau PET burden in early‐onset Alzheimer's disease
Pathogenic variants in the Longitudinal Early‐onset Alzheimer's Disease Study cohort
Profiling baseline performance on the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection